190 related articles for article (PubMed ID: 1839650)
21. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
[TBL] [Abstract][Full Text] [Related]
22. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
[TBL] [Abstract][Full Text] [Related]
23. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
24. Biosynthetic labeling of beta-hexosaminidase B: inhibition of the cellular uptake of lysosomal secretions containing [3H]hexosaminidase B by insulin-like growth factor-II in rat C6 glial cells.
Kessler U; Aumeier S; Funk B; Kiess W
Mol Cell Endocrinol; 1992 Dec; 90(1):147-53. PubMed ID: 1301395
[TBL] [Abstract][Full Text] [Related]
25. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
Christopher R; Rangaswamy GR; Shetty KT
Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
[TBL] [Abstract][Full Text] [Related]
26. [Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases].
Zwierz K; Juszkiewicz J; Arciuch L; Gindzieński A
Postepy Biochem; 1992; 38(3):127-32. PubMed ID: 1461844
[No Abstract] [Full Text] [Related]
27. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
Phaneuf D; Wakamatsu N; Huang JQ; Borowski A; Peterson AC; Fortunato SR; Ritter G; Igdoura SA; Morales CR; Benoit G; Akerman BR; Leclerc D; Hanai N; Marth JD; Trasler JM; Gravel RA
Hum Mol Genet; 1996 Jan; 5(1):1-14. PubMed ID: 8789434
[TBL] [Abstract][Full Text] [Related]
28. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
Prence EM; Natowicz MR; Zalewski I
Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
[TBL] [Abstract][Full Text] [Related]
29. Preferential beta-hexosaminidase (Hex) A (alpha beta) formation in the absence of beta-Hex B (beta beta) due to heterozygous point mutations present in beta-Hex beta-chain alleles of a motor neuron disease patient.
Banerjee P; Boyers MJ; Berry-Kravis E; Dawson G
J Biol Chem; 1994 Feb; 269(7):4819-26. PubMed ID: 8106452
[TBL] [Abstract][Full Text] [Related]
30. Prenatal diagnosis for Tay-Sachs disease using chorionic villus sampling.
Grebner EE; Jackson LG
Prenat Diagn; 1985; 5(5):313-20. PubMed ID: 2933645
[TBL] [Abstract][Full Text] [Related]
31. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
Gort L; de Olano N; Macías-Vidal J; Coll MA;
Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
[TBL] [Abstract][Full Text] [Related]
32. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
[TBL] [Abstract][Full Text] [Related]
33. First trimester prenatal diagnosis of Sandhoff's disease.
Giles L; Cooper A; Fowler B; Sardharwalla IB; Donnai P
Prenat Diagn; 1988 Mar; 8(3):199-205. PubMed ID: 2967473
[TBL] [Abstract][Full Text] [Related]
34. Long-term intracellular retention of hexosaminidase A by Tay-Sachs disease brain and lung cells in vitro.
Brooks SE; Hoffman LM; Amsterdam D; Adachi M; Schneck L
J Neurosci Res; 1981; 6(3):381-8. PubMed ID: 6457913
[TBL] [Abstract][Full Text] [Related]
35. A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.
Hou Y; McInnes B; Hinek A; Karpati G; Mahuran D
J Biol Chem; 1998 Aug; 273(33):21386-92. PubMed ID: 9694901
[TBL] [Abstract][Full Text] [Related]
36. Characterization of polypeptides serologically and structurally related to hexosaminidase in cultured fibroblasts.
Tsui F; Mahuran DJ; Lowden JA; Mosmann T; Gravel RA
J Clin Invest; 1983 Apr; 71(4):965-73. PubMed ID: 6833496
[TBL] [Abstract][Full Text] [Related]
37. Two small deletion mutations of the HEXB gene are present in DNA from a patient with infantile Sandhoff disease.
McInnes B; Brown CA; Mahuran DJ
Biochim Biophys Acta; 1992 Apr; 1138(4):315-7. PubMed ID: 1532910
[TBL] [Abstract][Full Text] [Related]
38. Ganglioside storage, hexosaminidase lability, and urinary oligosaccharides in adult Sandhoff's disease.
Bolhuis PA; Oonk JG; Kamp PE; Ris AJ; Michalski JC; Overdijk B; Reuser AJ
Neurology; 1987 Jan; 37(1):75-81. PubMed ID: 2948136
[TBL] [Abstract][Full Text] [Related]
39. Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.
Kustermann-Kuhn B; Harzer K
Hum Genet; 1983; 65(2):172-5. PubMed ID: 6228513
[TBL] [Abstract][Full Text] [Related]
40. Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis.
Kaur M; Verma IC
Indian J Pediatr; 1995; 62(4):485-9. PubMed ID: 10829910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]